⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCRX News
BioCryst Pharmaceuticals Inc
Form 8-K
sec.gov
BCRX
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
BCRX
AM Best Affirms Credit Ratings of Compañía Internacional de Seguros, S.A.
businesswire.com
BCRX
AM Best Affirms Credit Ratings of Compañía Internacional de Seguros, S.A.
businesswire.com
BCRX
BioCryst to Present at Upcoming Investor Conference
globenewswire.com
BCRX
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
globenewswire.com
BCRX
ADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer
globenewswire.com
BCRX
ANNX
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26
globenewswire.com
BCRX
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCRX
CD137 Targeted Therapy Research Report 2026-2030: Market Opportunities, Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights - ResearchAndMarkets.com
businesswire.com
GMAB
ABL
BNTX
BCRX